Corrigendum to: Medications Non-adherence Reasoning Scale (MedNARS): Development and psychometric properties appraisal
Hamid Allahverdipour, Majid Badri, Abdolreza Shaghaghi, Hassan Mahmoodi, Haleh Heizomi, Shayesteh Shirzadi, Mohammad Asghari-Jafarabadi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Practices and Patient Outcomes
Dear Editor,
We are writing to formally submit a corrigendum for our article titled “Medications Non-adherence Reasoning Scale (MedNARS): Development and Psychometric Properties Appraisal,” published in Health Promotion Perspectives on September 11, 2023. 1
We have identified an error in the Ethical Approval section of the manuscript. The original article inadvertently listed the approval code as IR.TBZMED.REC.1396.435, whereas the correct code should be IR.TBZMED.REC.1399.499.
Ethical Approval
Ethical approval for the study protocol was obtained from the Medical Ethics Board of Trustees (MEBoT) affiliated with the Tabriz University of Medical Sciences (IR.TBZMED.REC.1399.499), and all the participants voluntarily signed an informed consent form to participate in the study before the interviews and data collection stage.
We confirm that this correction applies only to the ethical approval documentation and does not affect the study’s methodology, results, conclusions, or scientific validity.
The reference list from the paper itself. Each links out to its DOI / PubMed record.